Protocol for the PINCER trial: a cluster randomised trial comparing the effectiveness of a pharmacist-led IT-based intervention with simple feedback in reducing rates of clinically important errors in medicines management in general practices

[1]  A. Sheikh,et al.  Correction: Protocol for the PINCER trial: a cluster randomised trial comparing the effectiveness of a pharmacist-led IT-based intervention with simple feedback in reducing rates of clinically important errors in medicines management in general practices , 2010, Trials.

[2]  D. Cousins,et al.  The National Coordinating Council for Medication Error Reporting and Prevention: promoting patient safety and quality through innovation and leadership. , 2008, Joint Commission journal on quality and patient safety.

[3]  R. Parker,et al.  Communities and Local Government , 2008 .

[4]  M. Pirmohamed,et al.  Which drugs cause preventable admissions to hospital? A systematic review. , 2007, British journal of clinical pharmacology.

[5]  M. Stecker,et al.  Root cause analysis. , 2007, Journal of vascular and interventional radiology : JVIR.

[6]  Grazyna Adamiak,et al.  Methods for the economic evaluation of health care programmes, 3rd ed , 2006 .

[7]  S. Royal,et al.  Interventions in primary care to reduce medication related adverse events and hospital admissions: systematic review and meta-analysis , 2006, Quality and Safety in Health Care.

[8]  A D Oxman,et al.  Audit and feedback: effects on professional practice and health care outcomes. , 2006, The Cochrane database of systematic reviews.

[9]  C. Marano,et al.  To err is human. Building a safer health system , 2005 .

[10]  T. Peters,et al.  Cluster randomized trials: Another problem for cost-effectiveness ratios , 2005, International Journal of Technology Assessment in Health Care.

[11]  S. Rodgers,et al.  Indicators for preventable drug related morbidity: application in primary care , 2004, Quality and Safety in Health Care.

[12]  Ewout W Steyerberg,et al.  Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements. , 2004, Journal of clinical epidemiology.

[13]  Jim Smith,et al.  Building a safer NHS for patients: improving medication safety , 2004 .

[14]  A. Oxman,et al.  Audit and feedback: effects on professional practice and health care outcomes. , 2003, The Cochrane database of systematic reviews.

[15]  A. Avery,et al.  Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study , 2003, Quality & safety in health care.

[16]  D. Bates,et al.  Incidence and preventability of adverse drug events among older persons in the ambulatory setting. , 2003, JAMA.

[17]  J. Cantrill,et al.  How the use of preventable drug-related mobidity indicators can improve medicines management in primary care , 2003 .

[18]  C. Bond,et al.  Practice‐based pharmaceutical services: a systematic review , 2002 .

[19]  S. Pocock,et al.  Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practiceand problems , 2002, Statistics in medicine.

[20]  A. Sheikh,et al.  Safer medicines management in primary care. , 2002, The British journal of general practice : the journal of the Royal College of General Practitioners.

[21]  C. Vincent,et al.  Causes of prescribing errors in hospital inpatients: a prospective study , 2002, The Lancet.

[22]  Nick Freemantle,et al.  A randomised controlled trial of the effect of educational outreach by community pharmacists on prescribing in UK general practice. , 2002, The British journal of general practice : the journal of the Royal College of General Practitioners.

[23]  W. Shih,et al.  Current Controlled Trials in Cardiovascular Medicine , 2002 .

[24]  P. Maurette,et al.  [To err is human: building a safer health system]. , 2002, Annales francaises d'anesthesie et de reanimation.

[25]  Jeremy M. Grimshaw,et al.  Changing Provider Behavior: An Overview of Systematic Reviews of Interventions , 2001, Medical care.

[26]  J. Krska,et al.  Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. , 2001, Age and ageing.

[27]  N. N. Available.  World medical association declaration of Helsinki , 2000, Chinese Journal of Integrative Medicine.

[28]  Anthony J Avery,et al.  A survey of prescription errors in general practice , 2001 .

[29]  A. Wall,et al.  Book ReviewTo Err is Human: building a safer health system Kohn L T Corrigan J M Donaldson M S Washington DC USA: Institute of Medicine/National Academy Press ISBN 0 309 06837 1 $34.95 , 2000 .

[30]  J. Reason.  Human error: models and management , 2000, BMJ : British Medical Journal.

[31]  S. Assmann,et al.  Subgroup analysis and other (mis)uses of baseline data in clinical trials , 2000, The Lancet.

[32]  A D Oxman,et al.  Educational outreach visits: Effects on professional practice and health care outcomes (Cochrane review) , 2000, The Cochrane database of systematic reviews.

[33]  A. Granås,et al.  The effect of pharmaceutical review of repeat prescriptions in general practice , 1999 .

[34]  S. Hollis,et al.  What is meant by intention to treat analysis? Survey of published randomised controlled trials , 1999, BMJ.

[35]  E. Hurley,et al.  Outcomes of an educational‐outreach service for community medical practitioners: non‐steroidal anti‐inflammatory drugs , 1999, The Medical journal of Australia.

[36]  J. Sterne,et al.  Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review. , 1999, Health technology assessment.

[37]  Roel Bosker,et al.  Multilevel analysis : an introduction to basic and advanced multilevel modeling , 1999 .

[38]  A Briggs,et al.  The Distribution of Health Care Costs and Their Statistical Analysis for Economic Evaluation , 1998, Journal of health services research & policy.

[39]  W W Hauck,et al.  Should we adjust for covariates in nonlinear regression analyses of randomized trials? , 1998, Controlled clinical trials.

[40]  J M Bland,et al.  The intracluster correlation coefficient in cluster randomisation , 1998, BMJ.

[41]  H. Cohen,et al.  A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. , 1996, The American journal of medicine.

[42]  N. Dickey,et al.  Systems analysis of adverse drug events. , 1996, JAMA.

[43]  D. Bates,et al.  Systems analysis of adverse drug events. ADE Prevention Study Group. , 1995, JAMA.

[44]  M J Al,et al.  Costs, effects and C/E-ratios alongside a clinical trial. , 1994, Health economics.

[45]  E. Ziegel,et al.  Root Cause Analysis , 2010, Journal of Clinical Engineering.

[46]  A. B. Prasad,et al.  British National Formulary , 1994 .

[47]  S B Soumerai,et al.  Principles of educational outreach ('academic detailing') to improve clinical decision making. , 1990, JAMA.

[48]  S. Wilson.  Methods for the economic evaluation of health care programmes , 1987 .